|
NO167087C
(no)
|
1985-10-25 |
1991-10-02 |
Secr Defence Brit |
Fremgangsmaate for fremstilling av en nitratester.
|
|
US5561227A
(en)
|
1991-07-23 |
1996-10-01 |
Schering Corporation |
Process for the stereospecific synthesis of azetidinones
|
|
LT3300B
(en)
|
1992-12-23 |
1995-06-26 |
Schering Corp |
Combination of a cholesterol biosynhtesis inhibitor and a beta- lactam cholesterol absorbtion inhibitor
|
|
HUP9901979A3
(en)
|
1995-09-01 |
2000-03-28 |
Upjohn Co |
Phenyloxazolidinones having a c-c bond to 4-8 membered heterocyclic rings and pharmaceutical compositions containing the same
|
|
WO2000005214A2
(en)
|
1998-07-24 |
2000-02-03 |
Pfizer Inc. |
Isoquinolines as urokinase inhibitors
|
|
ES2330731T3
(es)
|
2001-08-30 |
2009-12-15 |
Chemocentryx, Inc. |
Compuestos biciclicos como inhibidores de la union de quimioquina a us28.
|
|
MXPA05000053A
(es)
|
2002-07-12 |
2005-04-08 |
Aventis Pharma Gmbh |
Benzoilureas heterociclicamente sustituidas, metodo para su produccion y su uso como medicamentos.
|
|
DE60335827D1
(de)
|
2002-12-20 |
2011-03-03 |
Merck Sharp & Dohme |
1-(amino)indane als edg-rezeptoragonisten
|
|
JP4660199B2
(ja)
|
2002-12-23 |
2011-03-30 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
置換１−ピペリジン−４−イル−４−アゼチジン−３−イル−ピペラジン誘導体およびそれらのニューロキニン拮抗薬としての使用
|
|
GB0510204D0
(en)
|
2005-05-19 |
2005-06-22 |
Chroma Therapeutics Ltd |
Enzyme inhibitors
|
|
AU2007227274A1
(en)
*
|
2006-03-21 |
2007-09-27 |
Epix Delaware, Inc. |
S1P receptor modulating compounds
|
|
WO2008053131A1
(en)
|
2006-10-30 |
2008-05-08 |
Chroma Therapeutics Ltd. |
Hydroxamates as inhibitors of histone deacetylase
|
|
US20090137549A1
(en)
|
2006-11-09 |
2009-05-28 |
Paul John Edward |
Novel compounds useful for the treatment of degenerative & inflamatory diseases
|
|
WO2010056788A1
(en)
|
2008-11-17 |
2010-05-20 |
Merck Sharp & Dohme Corp. |
Anti-hypercholesterolemic compounds
|
|
MX2011008452A
(es)
|
2009-02-10 |
2011-12-16 |
Astrazeneca Ab |
Derivados de triazolo [4,3-b] piridazina y sus usos para el cancer de prostata.
|
|
WO2011036889A1
(ja)
|
2009-09-25 |
2011-03-31 |
武田薬品工業株式会社 |
複素環化合物
|
|
GB201002563D0
(en)
|
2010-02-15 |
2010-03-31 |
Cambridge Entpr Ltd |
Compounds
|
|
WO2011143365A1
(en)
|
2010-05-13 |
2011-11-17 |
Amgen Inc. |
Nitrogen heterocyclic compounds useful as pde10 inhibitors
|
|
MX2012013128A
(es)
|
2010-05-13 |
2013-03-20 |
Amgen Inc |
Compuestos heterociclicos de nitrogeno como inhibidores de la fosfodiesterasa 10.
|
|
WO2012082947A1
(en)
|
2010-12-16 |
2012-06-21 |
Irm Llc |
Compounds and compositions as tgr5 agonists
|
|
EP2545964A1
(en)
|
2011-07-13 |
2013-01-16 |
Phenex Pharmaceuticals AG |
Novel FXR (NR1H4) binding and activity modulating compounds
|
|
MX336431B
(es)
|
2012-05-09 |
2016-01-18 |
Zoetis Services Llc |
Derivados de azetidina como agentes antiparasitarios.
|
|
TW201408652A
(zh)
|
2012-07-11 |
2014-03-01 |
Hoffmann La Roche |
作爲ＲＯＲｃ調節劑之芳基磺內醯胺衍生物
|
|
CA2891569A1
(en)
|
2012-11-16 |
2014-05-22 |
Bristol-Myers Squibb Company |
Pyrrolidine gpr40 modulators
|
|
SG11201602935PA
(en)
|
2013-10-17 |
2016-05-30 |
Abbvie Deutschland |
Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
KR20160100408A
(ko)
|
2014-01-06 |
2016-08-23 |
리젠 파마슈티컬스 소시에떼 아노님 |
신규한 글루타미나제 저해제
|
|
FR3017867A1
(fr)
*
|
2014-02-21 |
2015-08-28 |
Inventiva |
Nouveaux composes de type phenylazetidine carboxylate ou carboxamide
|
|
EP3140296B1
(en)
|
2014-05-07 |
2018-04-11 |
Bristol-Myers Squibb Company |
Pyrrolidine gpr40 modulators for the treatment of diseases such as diabetes
|
|
EP3191453B1
(en)
|
2014-09-09 |
2019-10-23 |
Bristol-Myers Squibb Company |
Phenyl-(aza)cycloalkyl carboxylic acid gpr120 modulators
|
|
US11219625B2
(en)
|
2015-07-24 |
2022-01-11 |
Yale University |
Inhibitors of N-linked glycosylation and methods using same
|
|
JP6697074B2
(ja)
|
2015-10-12 |
2020-05-20 |
チョン クン ダン ファーマシューティカル コーポレーション |
ヒストン脱アセチル化酵素６阻害剤としてのオキサジアゾールアミン誘導体化合物及びこれを含有する薬剤学的組成物
|
|
EP3409658B9
(en)
|
2016-01-29 |
2024-07-17 |
ONO Pharmaceutical Co., Ltd. |
Tetrahydronaphthalene derivative
|
|
DK3426243T3
(da)
|
2016-03-09 |
2021-07-19 |
Raze Therapeutics Inc |
3-phosphoglyceratdehydrogenase-inhibitorer og anvendelser deraf
|
|
US20200321533A1
(en)
|
2016-05-24 |
2020-10-08 |
President And Fellows Of Harvard College |
Compounds for organic light emitting diode materials
|
|
CA2968836C
(en)
|
2016-06-13 |
2025-09-02 |
Gilead Sciences, Inc. |
FXR MODULATING COMPOUNDS (NR1H4)
|
|
NZ748641A
(en)
|
2016-06-13 |
2020-04-24 |
Gilead Sciences Inc |
Fxr (nr1h4) modulating compounds
|
|
WO2018106818A1
(en)
|
2016-12-07 |
2018-06-14 |
Kura Oncology, Inc. |
Methods of promoting beta cell proliferation
|
|
AR110988A1
(es)
|
2017-02-21 |
2019-05-22 |
Sanofi Sa |
Compuestos de azetidina como moduladores de gpr119 para el tratamiento de la diabetes, la obesidad, la dislipidemia y trastornos relacionados
|
|
JP7365332B2
(ja)
|
2017-08-07 |
2023-10-19 |
ジョイント・ストック・カンパニー “バイオキャド” |
Ｃｄｋ８／１９阻害薬としての新規ヘテロ環式化合物
|
|
WO2019141803A1
(en)
|
2018-01-19 |
2019-07-25 |
Idorsia Pharmaceuticals Ltd |
C5a receptor modulators
|
|
JP6828191B2
(ja)
|
2018-08-16 |
2021-02-10 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
血漿カリクレイン阻害剤としての複素芳香族カルボキサミド誘導体
|
|
JP7571006B2
(ja)
|
2018-08-17 |
2024-10-22 |
ジェネンテック， インコーポレイテッド |
乳がんの処置のための診断的および治療的方法
|
|
WO2020071550A1
(ja)
|
2018-10-04 |
2020-04-09 |
京都薬品工業株式会社 |
Ｃｄｋ８阻害剤およびその用途
|
|
EP3873605B1
(en)
|
2018-10-30 |
2024-10-23 |
Gilead Sciences, Inc. |
Compounds for inhibition of alpha4beta7 integrin
|
|
CN111484479B
(zh)
|
2019-01-25 |
2023-06-13 |
四川科伦博泰生物医药股份有限公司 |
氮杂环化合物、包含其的药物组合物及其制备方法和用途
|
|
MX2022000083A
(es)
|
2019-07-03 |
2022-02-03 |
Hoffmann La Roche |
Inhibidores de monoacilglicerol lipasa (magl) heterociclicos.
|
|
MX2022001820A
(es)
|
2019-08-20 |
2022-03-17 |
Ono Pharmaceutical Co |
Sal y forma cristalina de un compuesto que tiene actividad agonista para el receptor 5 de esfingosina-1-fosfato [acido (2s,3r,4e)-2-amino-3-hidroxioctadeca-4-enil-1-fosforico (s1p5).
|
|
CN112887914A
(zh)
*
|
2019-11-30 |
2021-06-01 |
深圳市海思半导体有限公司 |
终端间定位方法及装置
|
|
CN111704613B
(zh)
|
2020-06-23 |
2021-07-06 |
中国人民解放军军事科学院军事医学研究院 |
咪唑类衍生物及其作为trpv4抑制剂的用途
|
|
KR20230124992A
(ko)
|
2020-12-23 |
2023-08-28 |
셀진 코포레이션 |
신경변성 질환의 치료를 위한 카르복실산 함유 인다닐화합물
|
|
AU2022291768A1
(en)
*
|
2021-06-16 |
2023-11-30 |
Celgene Corporation |
Azetidinyl compounds comprising a carboxylic acid group for the treatment of neurodegenerative diseases
|